NCT03049020

Brief Summary

Based on a prospective study, to evaluate how pre-operative pelvic floor status - the presence of injury to the musculus levator ani - may influence the results of laparoscopic sacrocolpopexy. The investigators hope to confirm or disprove the hypothesis that the presence of such injury increases the risk of post-operative prolapse recurrence

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2014

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 10, 2015

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

February 9, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

February 9, 2017

Status Verified

February 1, 2017

Enrollment Period

3.2 years

First QC Date

December 10, 2015

Last Update Submit

February 8, 2017

Conditions

Keywords

pelvic organ prolapsesacrocolpopexypelvic floor ultrasound

Outcome Measures

Primary Outcomes (1)

  • Objective cure rate

    The objective cure will be defined as absence of pelvic organ prolapse. Number of failures in each group: failure is defined as pelvic organ prolapse stage II or higher using the POPQ system during the clinical examination, or as a descent 1 cm below the lower edge of the pubic bone based on ultrasound examination

    One year

Secondary Outcomes (10)

  • Genital hiatus size

    One year

  • Distance of mesh from the bladder neck

    One year

  • Lowest position of the mesh

    One year

  • ICIQ-UI SF

    One year

  • PISQ 12

    One year

  • +5 more secondary outcomes

Study Arms (2)

With levator ani avulsion

Patients indicated for sacrocolpopexy for pelvic organ prolapse and suffering with levator ani avulsion

Procedure: laparoscopic sacrocolpopexy

Without levator ani avulsion

Patients indicated for sacrocolpopexy for pelvic organ prolapse and without levator ani avulsion

Procedure: laparoscopic sacrocolpopexy

Interventions

standard laparoscopic sacrocolpopexy for prolapse treatment

With levator ani avulsionWithout levator ani avulsion

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Age over 18, symptomatic pelvic organ prolapse stage II or higher (according to the International Continence Society Pelvic Organ Prolapse quantification system - POPQ) in anterior and apical (central) compartment

You may qualify if:

  • Age over 18
  • signed informed consent
  • symptomatic pelvic organ prolapse stage II or higher (according to the International Continence Society Pelvic Organ Prolapse quantification system - POPQ) in anterior and apical (central) compartment
  • agreement with postoperative follow-up

You may not qualify if:

  • Previous pelvic reconstructive mesh surgery
  • Isolated posterior compartment prolapse
  • Previous radiotherapy in lesser pelvis
  • Contraindication of laparoscopic sacrocolpopexy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

General University Hospital

Prague, Prague, 12800, Czechia

RECRUITING

Vladimir Kalis

Pilsen, Czechia

RECRUITING

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Jaromir Masata, MD, Ph.D.

    Charles University, Czech Republic

    STUDY CHAIR

Central Study Contacts

Jaromir Masata, MD, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Kamil Svabik, MD, Ph.D.

Study Record Dates

First Submitted

December 10, 2015

First Posted

February 9, 2017

Study Start

October 1, 2014

Primary Completion

December 1, 2017

Study Completion

December 1, 2018

Last Updated

February 9, 2017

Record last verified: 2017-02

Locations